FDA panel favors Glaxo epilepsy drug - Health - msnbc.com

Links shared publicly online about this topic.

  • 955
    total visits

FDA panel favors Glaxo epilepsy drug - Health - msnbc.com

msnbc.msn.com

Federal health advisers have ruled that GlaxoSmithKline's epilepsy drug Potiga effectively controls seizures.

View full resource at msnbc.msn.com

Tags: Seizure, Epilepsy, Drug, FDA, GlaxoSmithKline, Epilepsy Medication

  • Share

Most Recently Shared on August 11, 2010 at 7:10 pm By:

FDA Panel Backs Proposed Epilepsy Drug - WSJ.com

online.wsj.com — “A Food and Drug Administration panel Wednesday backed a proposed epilepsy drug called Potiga developed by Valeant Pharmaceuticals International and GlaxoSmithKline PLC.View full resource at online.wsj.com

  • View Related
  • Share

Most Recently Shared on August 12, 2010 at 11:11 am By:

Epilepsy_Wisdom Epilepsy OW OW Health

FDA Panel Backs Proposed Epilepsy Drug: A Food and Drug Administration panel Wednesday backed a proposed epilepsy ... http://bit.ly/9WHUWw

2 years ago...

FDA advisory committee votes in favor of investigational anti-epileptic drug ezogabine

news-medical.net — “GlaxoSmithKline and Valeant Pharmaceuticals International announced today that a U.S. Food and Drug Administration advisory committee voted unanimously that clinical studies had provided substantial evidence of the effectiveness of ezogabine as adjunctive treatment for adults with partial-onset seizures.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on August 12, 2010 at 10:48 am By:

Epilepsy_News News-Medical.Net Health News

Epilepsy News: FDA advisory committee votes in favor of investigational anti-epileptic drug ezogabine: GlaxoSmithK... http://bit.ly/bDPd5k

2 years ago...

Advertisement